Establishment of a transgenic mouse model with liver-specific expression of secretory immunoglobulin D

Science China Life Sciences

Volumn 55, Issue 3, 2012, Pages 219-227

  Wang, Ping ^a   Wei, Zhi Guo ^b   Yan, Bo Wen ^a   Huang, Tan ^a   Gou, Ke Mian ^a   Dai, Yun Ping ^a   Zheng, Min ^a   Wang, MeiLi ^a   Cheng, Xue Qian ^a   Wang, Xi Feng ^a   Xu, Chen ^a   Sun, Yi ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

HIDS; liver specific expression vector; MVK; sIgD

Indexed keywords

IMMUNOGLOBULIN D;

ANIMAL; ARTICLE; B LYMPHOCYTE; BIOLOGICAL MODEL; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; KIDNEY; LIVER; MALE; METABOLISM; METHODOLOGY; MOUSE; MUTATION; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SPLEEN; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; BLOTTING, SOUTHERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; IMMUNOGLOBULIN D; KIDNEY; LIVER; MALE; MICE; MICE, TRANSGENIC; MODELS, GENETIC; MUTATION; POLYMERASE CHAIN REACTION; SPLEEN; TRANSGENES;

MUS; MUS MUSCULUS;

EID: 84859738054     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-012-4301-3     Document Type: Article

References (39)

1. Drenth J P, Prieur A M. Occurrence of arthritis in hyper-immunoglobulinaemia D. Ann Rheum Dis, 1993, 52: 765-766.
2. Drenth J P, Boom B W, Toonstra J, et al. Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group. Arch Dermatol, 1994, 130: 59-65.
3. Drenth J P, Haagsma C J, van der Meer J W. Hyperimmuno-globulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore), 1994, 73: 133-144.
4. van der Meer J W, Vossen J M, Radl J, et al. Hyperimmuno-globulinaemia D and periodic fever: a new syndrome. Lancet, 1984, 1: 1087-1090.
5. Naruto T, Nakagishi Y, Mori M, et al. Hyper-IgD syndrome with novel mutation in a Japanese girl. Mod Rheumatol, 2009, 19: 96-99.
6. Yoshimura K, Wakiguchi H. Hyperimmunoglobulinemia D syndrome successfully treated with a corticosteroid. Pediatr Int, 2002, 44: 326-327.
7. Klasen I S, Goertz J H, van de Wiel G A, et al. Hyper-immuno-globulin A in the hyperimmunoglobulinemia D syndrome. Clin Diagn Lab Immun, 2001, 8: 58-61.
8. Frenkel J, Rijkers G T, Mandey S H, et al. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmuno-globulinemia D and periodic fever syndrome. Arthrit Rheumat, 2002, 46: 2794-2803.
9. Drenth J P, Cuisset L, Grateau G, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet, 1999, 22: 178-181.
10. Simon A, Cuisset L, Vincent M F, et al. Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med, 2001, 135: 338-343.
11. Houten S M, van Woerden C S, Wijburg F A, et al. Carrier frequency of the V377I (1129G> A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet, 2003, 11: 196-200.
12. Aringer M. Periodic fever syndromes-a clinical overview. Acta Med Austriaca, 2004, 31: 8-12.
13. Drenth J P, van der Meer J W. Hereditary periodic fever. N Engl J Med, 2001, 345: 1748-1757.
14. Hager E J, Tse H M, Piganelli J D, et al. Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome. J Inherit Metab Dis, 2007, 30: 888-895.
15. Ammouri W, Cuisset L, Rouaghe S, et al. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology, 2007, 46: 1597-1600.
16. Dikeacou T C, van Joost T, Cormane R H. The recruitment of inflammatory cells using the skin-window technique. Arch Dermatol Res, 1979, 265: 1-7.
17. Chen K, Cerutti A. New insights into the enigma of immunoglobulin D. Immunol Rev, 2010, 237: 160-179.
18. Vladutiu A O. Immunoglobulin D: properties, measurement, and clinical relevance. Clin Diagn Lab Immun, 2000, 7: 131-140.
19. Gorski K, Carneiro M, Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell, 1986, 47: 767-776.
20. Herbomel P, Rollier A, Tronche F, et al. The rat albumin promoter is composed of six distinct positive elements within 130 nucleotides. Mol Cell Biol, 1989, 9: 4750-4758.
21. Heard J M, Herbomel P, Ott M O, et al. Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system. Mol Cell Biol, 1987, 7: 2425-2434.
22. Kraus C L, Culican S M. Nummular keratopathy in a patient with Hyper-IgD Syndrome. Pediatr Rheumatol Online J, 2009, 7: 14.
23. Sornsakrin M, Wenner K, Ganschow R. B cell cytopenia in two brothers with hyper-IgD and periodic fever syndrome. Eur J Pediatr, 2009, 168: 825-831.
24. Attout H, Guez S, Ranaivo I, et al. A patient with hyper-IgD syndrome responding to simvastatin treatment. Eur J Intern Med, 2008, 19: e82-83.
25. Coban E, Terzioglu E. A patient with hyper-IgD syndrome in Antalya, Turkey. Clin Rheumatol, 2004, 23: 177-178.
26. Tronche F, Rollier A, Bach I, et al. The rat albumin promoter: cooperation with upstream elements is required when binding of APF/HNF1 to the proximal element is partially impaired by mutation or bacterial methylation. Mol Cell Biol, 1989, 9: 4759-4766.
27. Zhang D E, Ge X, Rabek J P, et al. Functional analysis of the trans-acting factor binding sites of the mouse alpha-fetoprotein proximal promoter by site-directed mutagenesis. J Biol Chem, 1991, 266: 21179-21185.
28. Izban M G, Papaconstantinou J. Cell-specific expression of mouse albumin promoter-evidence for cell-specific DNA elements within the proximal promoter region and cis-acting DNA elements upstream of -160. J Biol Chem, 1989, 264: 9171-9179.
29. Pinkert C A, Ornitz D M, Brinster R L, et al. An albumin enhancer located 10-kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Gene Dev, 1987, 1: 268-276.
30. Hu J M, Camper S A, Tilghman S M, et al. Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes. Cell Growth Differ, 1992, 3: 577-588.
31. Clark A J, Cowper A, Wallace R, et al. Rescuing transgene expression by co-integration. Biotechnology (NY), 1992, 10: 1450-1454.
32. Tang B, Yu S, Zheng M, et al. High level expression of a functional human/mouse chimeric anti-CD20 monoclonal antibody in milk of transgenic mice. Transgenic Res, 2008, 17: 727-732.
33. Enjuanes L, Sola I, Castilla J, et al. Transgenic mice secreting coronavirus neutralizing antibodies into the milk. J Virology, 1998, 72: 3762-3772.
34. Fine J M, Rivat C, Lambin P, et al. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component. Biomedicine, 1974, 21: 119-125.
35. Fibbe W E, Jansen J. Prognostic factors in IgD myeloma: a study of 21 cases. Scand J Haematol, 1984, 33: 471-475.
36. Rowe D S, Hug K, Forni L, et al. Immunoglobulin-D as a lymphocyte receptor. J Exp Med, 1973, 138: 965-972.
37. Ligthart G J, Schuit H R, Hijmans W. Subpopulations of mononuclear cells in ageing: expansion of the null cell compartment and decrease in the number of T and B cells in human blood. Immunology, 1985, 55: 15-21.
38. Chen K, Xu W, Wilson M, et al. Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol, 2009, 10: 889-898.
39. Obici L, Manno C, Muda A O, et al. First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum, 2004, 50: 2966-2969.